NORTHERN PHARMACY GROUP LIMITEDActive
Key figures
Like most small UK companies, NORTHERN PHARMACY GROUP LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023/24Balance sheet structure
Filed accounts2019/20–2023/24
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2023/24 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 95,702 | 437,331 | 524,833 | 507,714 | 315,978 |
| Total assets | 689,249 | 1,017,238 | 1,137,219 | 2,217,146 | 2,262,180 |
| Total liabilities | 556,510 | 641,638 | 629,434 | 1,540,182 | 1,666,456 |
| Net assets / total equity | 132,739 | 375,600 | 507,785 | 676,964 | 595,724 |
| Average number of employees | 7 | 9 | 14 | 14 | 38 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: NORTHERN PHARMACY GROUP LIMITED
Company
NORTHERN PHARMACY GROUP LIMITED is a private limited company registered with Companies House under company number 11966607. It was incorporated on 29 Apr 2019. Its status is active. The registered office is in Newcastle upon tyne (NE3). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), dispensing chemist in specialised stores (47730).
Accounts
The latest accounts in the database are for 2023/24 (period ending 30 Apr 2024); the company files small company accounts (filleted). Net assets were £595,724, down 12% on the previous year. Cash at bank and in hand was £315,978. Total assets were £2,262,180 and total liabilities £1,666,456. The company had an average of 38 employees. Figures are available for 5 financial years (2019/20–2023/24).
Control and charges
The company has 2 current directors. 2 persons with significant control are registered. 3 of 5 registered charges are outstanding.
Filing deadlines
The next accounts are due by 28 Apr 2026. The next confirmation statement is due by 20 Jul 2027.